Evidence map›Paper›PMID 39247915›Full record

ArticleFrontiers in endocrinology2024

The relation between FT

Shuo Dong, FanRui Ding, Yuan Wang, Shuo Liu, Ran Bai, YuanYuan Liu, Yin Zhao, YueRan Zhu, MengXue Liu, Yuenan Liu and 1 more

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Shuo Dong *Department of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
FanRui Ding *Department of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yuan WangDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Shuo LiuDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Ran BaiDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
YuanYuan LiuDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yin ZhaoDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
YueRan ZhuDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
MengXue LiuDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yuenan LiuDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Qian XingDepartment of Endocrine and Metabolic Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Under the current pandemic of Corona Virus Disease 2019 (COVID-19), The relationship between fatigue and COVID-19 has been found. Infection with COVID-19 is associated with fatigue long after the acute phase of COVID-19. Understanding the association of thyroid hormones levels with post-COVID condition, such as fatigue, is necessary to improve quality of life. Methods: This population-based cohort study was conducted in Dalian, China, from December 2022, to March 2023, using a Yidu Core platform in the First Affiliated Hospital of Dalian Medical University, that integrates medical records, laboratory tests, and all diagnosis and treatment information based on patients in hospital. Eligible individuals were 40 patients with COVID-19, Divided them into fatigue group and non-fatigue group following up by telephone using the FS-14 scale after 6 months. The primary outcomes were the diagnoses of fatigue. The association between thyroid hormones levels and post-COVID condition, such as fatigue, was assessed using logistic regression analysis. Results: Compared with the non-fatigue group, the FT Conclusions: Most people still have fatigue 6 months after COVID-19 infection. FT

Indexed as

COVID-19FatigueTriiodothyronineAdultAgedChinaCohort StudiesFemaleHumansMaleMiddle AgedSARS-CoV-2TriiodothyronineCOVID-19fatiguerisk factorSARS-CoV-2thyroid hormone

Identifiers

PMID39247915
PMCPMC11377235

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.